首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   5478512篇
  免费   443330篇
  国内免费   16680篇
耳鼻咽喉   78745篇
儿科学   175046篇
妇产科学   145911篇
基础医学   811332篇
口腔科学   157856篇
临床医学   509374篇
内科学   1003708篇
皮肤病学   128902篇
神经病学   461219篇
特种医学   214358篇
外国民族医学   1455篇
外科学   821388篇
综合类   153300篇
现状与发展   24篇
一般理论   3051篇
预防医学   458497篇
眼科学   131428篇
药学   395606篇
  23篇
中国医学   14888篇
肿瘤学   272411篇
  2021年   57912篇
  2019年   65236篇
  2018年   81523篇
  2017年   63807篇
  2016年   70881篇
  2015年   82736篇
  2014年   117491篇
  2013年   183620篇
  2012年   157758篇
  2011年   167912篇
  2010年   138913篇
  2009年   136349篇
  2008年   152564篇
  2007年   163939篇
  2006年   170487篇
  2005年   164534篇
  2004年   164896篇
  2003年   154359篇
  2002年   143847篇
  2001年   219901篇
  2000年   218282篇
  1999年   194177篇
  1998年   79252篇
  1997年   73101篇
  1996年   70919篇
  1995年   66579篇
  1994年   60581篇
  1993年   55945篇
  1992年   145355篇
  1991年   139874篇
  1990年   134576篇
  1989年   130631篇
  1988年   120914篇
  1987年   118993篇
  1986年   112571篇
  1985年   109412篇
  1984年   87363篇
  1983年   76678篇
  1982年   55190篇
  1981年   50943篇
  1980年   47675篇
  1979年   78474篇
  1978年   60139篇
  1977年   52365篇
  1976年   49025篇
  1975年   49971篇
  1974年   57577篇
  1973年   55234篇
  1972年   51997篇
  1971年   47950篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
62.
63.
64.
65.
Major depressive disorder and other neuropsychiatric disorders are often managed with long-term use of antidepressant medication. Fluoxetine, an SSRI antidepressant, is widely used as a first-line treatment for neuropsychiatric disorders. However, fluoxetine has also been shown to increase the risk of metabolic diseases such as non-alcoholic fatty liver disease. Fluoxetine has been shown to increase hepatic lipid accumulation in vivo and in vitro. In addition, fluoxetine has been shown to alter the production of prostaglandins which have also been implicated in the development of non-alcoholic fatty liver disease. The goal of this study was to assess the effect of fluoxetine exposure on the prostaglandin biosynthetic pathway and lipid accumulation in a hepatic cell line (H4-II-E-C3 cells). Fluoxetine treatment increased mRNA expression of prostaglandin biosynthetic enzymes (Ptgs1, Ptgs2, and Ptgds), PPAR gamma (Pparg), and PPAR gamma downstream targets involved in fatty acid uptake (Cd36, Fatp2, and Fatp5) as well as production of 15-deoxy-Δ12,14PGJ2 a PPAR gamma ligand. The effects of fluoxetine to induce lipid accumulation were attenuated with a PTGS1 specific inhibitor (SC-560), whereas inhibition of PTGS2 had no effect. Moreover, SC-560 attenuated 15-deoxy-Δ12,14PGJ2 production and expression of PPAR gamma downstream target genes. Taken together these results suggest that fluoxetine-induced lipid abnormalities appear to be mediated via PTGS1 and its downstream product 15d-PGJ2 and suggest a novel therapeutic target to prevent some of the adverse effects of fluoxetine treatment.  相似文献   
66.
Cognitive Therapy and Research - Despite interest in psychological inflexibility as a marker of suicide risk, no measure of psychological inflexibility specific to SI exists. The present study...  相似文献   
67.
68.
69.
70.
Gestational trophoblastic neoplasia (GTN) patients are treated according to the eight-variable International Federation of Gynaecology and Obstetrics (FIGO) scoring system, that aims to predict first-line single-agent chemotherapy resistance. FIGO is imperfect with one-third of low-risk patients developing disease resistance to first-line single-agent chemotherapy. We aimed to generate simplified models that improve upon FIGO. Logistic regression (LR) and multilayer perceptron (MLP) modelling (n = 4191) generated six models (M1-6). M1, all eight FIGO variables (scored data); M2, all eight FIGO variables (scored and raw data); M3, nonimaging variables (scored data); M4, nonimaging variables (scored and raw data); M5, imaging variables (scored data); and M6, pretreatment hCG (raw data) + imaging variables (scored data). Performance was compared to FIGO using true and false positive rates, positive and negative predictive values, diagnostic odds ratio, receiver operating characteristic (ROC) curves, Bland-Altman calibration plots, decision curve analysis and contingency tables. M1-6 were calibrated and outperformed FIGO on true positive rate and positive predictive value. Using LR and MLP, M1, M2 and M4 generated small improvements to the ROC curve and decision curve analysis. M3, M5 and M6 matched FIGO or performed less well. Compared to FIGO, most (excluding LR M4 and MLP M5) had significant discordance in patient classification (McNemar's test P < .05); 55-112 undertreated, 46-206 overtreated. Statistical modelling yielded only small gains over FIGO performance, arising through recategorisation of treatment-resistant patients, with a significant proportion of under/overtreatment as the available data have been used a priori to allocate primary chemotherapy. Streamlining FIGO should now be the focus.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号